Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 501–600 of 1,009
A matter of life and death: stem cell survival in tissue regeneration and tumour formation
Soteriou, D., & Fuchs, Y. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.122 · Cited by 87
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
Wang, L., Cao, Z.-M., Zhang, L., Li, J.-M., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923599 · Cited by 106
Preterm birth is associated with xenobiotics and predicted by the vaginal metabolome
Kindschuh, W. F., Baldini, F., Liu, M. C., Gerson, K. D., Liao, J., Lee, H. H., Anton, L., Gajer, P., Ravel, J., Levy, M., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01293-8 · Cited by 101
Roderburg, C., & Luedde, T. (2014) · Gut Microbes · doi:10.4161/gmic.29599 · Cited by 87
Sheflin, A., Borresen, E., Wdowik, M., Rao, S., Brown, R., Heuberger, A., Broeckling, C., Weir, T., & Ryan, E. (2015) · Nutrients · doi:10.3390/nu7021282 · Cited by 85
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 85
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Lonardo, A., Ballestri, S., Targher, G., & Loria, P. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965143 · Cited by 86
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Chu, H., Williams, B., & Schnabl, B. (2018) · Liver Research · doi:10.1016/j.livres.2017.11.005 · Cited by 84
Oda, K., Uto, H., Mawatari, S., & Ido, A. (2015) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-014-0548-5 · Cited by 90
Cellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 83
Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes
Xie, G., Wang, X., Zhao, A., Yan, J., Chen, W., Jiang, R., Ji, J., Huang, F., Zhang, Y., Lei, S., et al. (2017) · Scientific Reports · doi:10.1038/srep45232 · Cited by 84
From MAFLD to hepatocellular carcinoma and everything in between
Bae, S. D. W., George, J., & Qiao, L. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002089 · Cited by 94
Jang, D., Shin, J., Shim, E., Ohtani, N., & Jeon, O. H. (2024) · Aging Cell · doi:10.1111/acel.14315 · Cited by 84
Self-citationSuppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
Metabolic and functional interplay between gut microbiota and fat-soluble vitamins
Stacchiotti, V., Rezzi, S., Eggersdorfer, M. L., & Galli, F. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1793728 · Cited by 89
Quercetin is a promising pancreatic lipase inhibitor in reducing fat absorption in vivo
Zhou, J.-F., Wang, W., Yin, Z., Zheng, G., Chen, J., Li, J., Chen, L., & Zhang, Q. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101248 · Cited by 91
Sakamoto, Y., Mima, K., Ishimoto, T., Ogata, Y., Imai, K., Miyamoto, Y., Akiyama, T., Daitoku, N., Hiyoshi, Y., Iwatsuki, M., et al. (2021) · Cancer Science · doi:10.1111/cas.15126 · Cited by 81
Ishikawa, H., Takaki, A., Tsuzaki, R., Yasunaka, T., Koike, K., Shimomura, Y., Seki, H., Matsushita, H., Miyake, Y., Ikeda, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100627 · Cited by 86
Jovanovich, A. J., Isakova, T., Block, G. A., Stubbs, J. R., Smits, G., Chonchol, M., & Miyazaki, M. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.06.017 · Cited by 85
Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
Liu, J., Sun, J., Yu, J., Chen, H., Zhang, D., Zhang, T., Ma, Y., Zou, C., Zhang, Z., Ma, L., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00399-z · Cited by 94
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
He, X., Ji, G., Jia, W. P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030300 · Cited by 88
Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota
Singh, V., Yeoh, B. S., Abokor, A. A., Golonka, R. M., Tian, Y., Patterson, A. D., Joe, B., Heikenwälder, M. F., & Vijay–Kumar, M. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1743492 · Cited by 84
Radun, R., & Trauner, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731707 · Cited by 80
Greten, T. F., Abou-Alfa, G. K., Cheng, A.-L., Duffy, A. G., El-Khoueiry, A. B., Finn, R. S., Galle, P. R., Goyal, L., He, A. R., Kaseb, A. O., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002794 · Cited by 80
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Stępień, M., Keski‐Rahkonen, P., Kiss, A., Robinot, N. R., Duarte‐Salles, T., Murphy, N., Perlemuter, G., Viallon, V., Tjønneland, A. M., Rostgaard‐Hansen, A. L., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33236 · Cited by 88
Sanyal, A. J., Ling, L., Beuers, U., DePaoli, A. M., Lieu, H. D., Harrison, S. A., & Hirschfield, G. M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100255 · Cited by 79
Sharma, R. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09903-3 · Cited by 75
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 85
Obesity: a perfect storm for carcinogenesis
Harris, B. H. L., Macaulay, V. M., Harris, D. A., Klenerman, P., Karpe, F., Lord, S., Harris, A. L., & Buffa, F. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10046-2 · Cited by 88
Bile acids in drug induced liver injury: Key players and surrogate markers
Schadt, H. S., Wolf, A., Pognan, F., Chibout, S., Merz, M., & Kullak-Ublick, G. A. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.12.017 · Cited by 86
Metaorganismal nutrient metabolism as a basis of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000036 · Cited by 80
Nakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79
Adams, L. A., Wang, Z., Liddle, C., Melton, P. E., Ariff, A., Chandraratna, H. S., Tan, J. T. H., Ching, H. L., Coulter, S., de Boer, B., et al. (2020) · Liver International · doi:10.1111/liv.14453 · Cited by 82
Hypoxia: The “Invisible Pusher” of Gut Microbiota
Han, N., Pan, Z., Liu, G., Yang, R., & Bi, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.690600 · Cited by 86
Intrahepatic microbes govern liver immunity by programming NKT cells
Leinwand, J. C., Paul, B., Chen, R., Xu, F., Sierra, M. A., Paluru, M. M., Nanduri, S., Alcantara, C. G., Shadaloey, S. A. A., Yang, F., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151725 · Cited by 76
Dietary interventions and precision nutrition in cancer therapy
Martínez-Garay, C., & Djouder, N. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.04.004 · Cited by 85
Brockhausen, J., Tay, S. S., Grzelak, C. A., Bertolino, P., Bowen, D. G., d’Avigdor, W., Teoh, N., Pok, S., Shackel, N. A., Gamble, J. R., et al. (2014) · Liver International · doi:10.1111/liv.12517 · Cited by 90
Diabetes and cancer, common threads and missing links
Hua, F., Yu, J., & Hu, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.006 · Cited by 90
Microbiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Detection technologies and metabolic profiling of bile acids: a comprehensive review
Liu, Y., Rong, Z., Xiang, D., Zhang, C., & Liu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0774-9 · Cited by 83
Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options
Cai, X., Cai, H., Wang, J., Yang, Q., Guan, J., Deng, J., & Chen, Z. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100977 · Cited by 83
Gut microbiota and associated metabolites: key players in high-fat diet-induced chronic diseases
Du, W., Zou, Z., Ye, B., & Zhou, Y. Q. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2494703 · Cited by 91
Li, R., Grimm, S. A., Chrysovergis, K., Kosak, J., Wang, X., Du, Y., Burkholder, A., Janardhan, K., Mav, D., Shah, R., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.012 · Cited by 78
Modeling the Impact of Antibiotic Exposure on Human Microbiota
Zhao, J., Murray, S., & LiPuma, J. J. (2014) · Scientific Reports · doi:10.1038/srep04345 · Cited by 80
Chiyonobu, N., Shimada, S., Akiyama, Y., Mogushi, K., Itoh, M., Akahoshi, K., Matsumura, S., Ogawa, K., Ono, H., Mitsunori, Y., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.012 · Cited by 86
Cell senescence in neuropathology: A focus on neurodegeneration and tumours
Carreno, G., Guiho, R., & Martinez‐Barbera, J. P. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12689 · Cited by 74
Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
Meijnikman, A. S., Herrema, H., Scheithauer, T. P. M., Kroon, J., Nieuwdorp, M., & Groen, A. K. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100301 · Cited by 75
Thomas, C. E., Luu, H. N., Wang, R., Xie, G., Adams‐Haduch, J. M., Jin, A., Koh, W., Jia, W. P., Behari, J., & Yuan, J. (2021) · Cancers · doi:10.3390/cancers13112648 · Cited by 82
Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis
Iida, N., Mizukoshi, E., Yamashita, T., Yutani, M., Seishima, J., Wang, Z., Arai, K., Okada, H., Yamashita, T., Sakai, Y., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00251-3 · Cited by 81
The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota
Wang, M., Yu, F., Zhang, Y., Chang, W., & Zhou, M. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68170 · Cited by 85
Giroud, J., Bouriez, I., Paulus, H., Pourtier, A., Debacq-Chainiaux, F., & Pluquet, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310788 · Cited by 73
Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet
Ju, M., Liu, Y., Li, M., Cheng, M., Zhang, Y., Deng, G., Kang, X., & Liu, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172457 · Cited by 80
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Rielland, M., Cantor, D. J., Graveline, R., Hajdu, C., Mara, L., de Diego Diaz, B., Miller, G., & David, G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72619 · Cited by 76
“In agreement with our observations, a recent study indicated that the senescence secretome promotes liver cancer progression (21).”
Li, C., Liu, C., Fu, M., Hu, K., Aizawa, K., Takahashi, S., Hiroyuki, S., Cheng, J., von Lintig, J., & Wang, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700738 · Cited by 75
Zhu, Y., Zhang, J., Wei, Y., Hao, J., Lei, Y., Zhao, W., Xiao, Y., & Sun, A. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00473-9 · Cited by 83
Huang, R., Xie, J., Liu, X., & Shen, M. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110393 · Cited by 79
Huang, Y., Yang, X. F., Meng, Y., Shao, C., Liao, J., Li, F., Li, R., Jing, Y., & Huang, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00683-5 · Cited by 82
Kang, Y., Cai, Y., & Yang, Y. X. (2021) · Liver Cancer · doi:10.1159/000521358 · Cited by 85
Sharma, R., Kumar, R., Sharma, A., Goel, A., & Padwad, Y. S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109068 · Cited by 80
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Qu, P., Rom, O., Li, K., Jia, L., Gao, X., Liu, Z., Ding, S., Zhao, M., Wang, H., Chen, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.013 · Cited by 83
Ablation of the p16INK4a tumour suppressor reverses ageing phenotypes of klotho mice
Sato, S., Kawamata, Y., Takahashi, A., Imai, Y., Hanyu, A., Okuma, A., Takasugi, M., Yamakoshi, K., Sorimachi, H., Kanda, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8035 · Cited by 77
Self-citationPathogenesis of hepatocellular carcinoma according to aetiology
Nault, J. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.006 · Cited by 85
Tesei, D., Jewczynko, A., Lynch, A., & Urbaniak, C. (2022) · Life · doi:10.3390/life12040495 · Cited by 87
Targeting cellular senescence in metabolic disease
Palmer, A. K., Tchkonia, T., & Kirkland, J. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101601 · Cited by 79
Lin, Z., Wu, J., Wang, J., Levesque, C. L., & Ma, X. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134643 · Cited by 87
Gut Microbiota: Modulation of Host Physiology in Obesity
Nehra, V., Allen, J. M., Mailing, L. J., Kashyap, P. C., & Woods, J. A. (2016) · Physiology · doi:10.1152/physiol.00005.2016 · Cited by 73
Chromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects
He, Q., Au, B., Kulkarni, M., Shen, Y., Lim, K. J., Maimaiti, J., Wong, C. K., Luijten, M. N. H., Chong, H. C., Lim, E. H., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0072-4 · Cited by 68
Zeng, H., Larson, K., Cheng, W., Bukowski, M. R., Safratowich, B. D., Liu, Z., & Hakkak, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108336 · Cited by 80
Li, N., Ma, P.-G., Li, Y., Shang, X., Nan, X., Shi, L., Han, X., Liu, J., Hong, Y., Li, Q., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2290315 · Cited by 77
Unno, T., Hisada, T., & Takahashi, S. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02649 · Cited by 72
Vanni, E., & Bugianesi, E. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.001 · Cited by 83
Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation
Maehara, N., Arai, S., Mori, M., Iwamura, Y., Kurokawa, J., Kai, T., Kusunoki, S., Taniguchi, K., Ikeda, K., Ohara, O., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.058 · Cited by 75
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 79
Self-citationThe influence of probiotics on bile acids in diseases and aging
Sivamaruthi, B. S., Fern, L. A., Rashidah Pg Hj Ismail, D. S. N., & Chaiyasut, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110310 · Cited by 73
Obesity and the liver: nonalcoholic fatty liver disease
Koppe, S. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.008 · Cited by 80
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either
Hartmann, P., Chu, H., Duan, Y., & Schnabl, B. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00370.2018 · Cited by 79
Shen, C., Wan, L., Wang, T., & Jiang, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104347 · Cited by 75
Arab, J. P., Arrese, M. A., & Shah, V. H. (2020) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 78
Gut microbiota: A new piece in understanding hepatocarcinogenesis
Zhou, A., Tang, L., Zeng, S., Lei, Y., Yang, S., & Tang, B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.002 · Cited by 80
Cellular mechanisms linking cancers to obesity
Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 77
Obesity and Pancreatic Cancer: Insight into Mechanisms
Eibl, G., & Rozengurt, E. (2021) · Cancers · doi:10.3390/cancers13205067 · Cited by 80
Wahlstrom, A. M., Brumbaugh, A. R., Sjöland, W., Olsson, L. M., Wu, H., Henricsson, M., Lundqvist, A., Makki, K., Hazen, S. L., Bergström, G. M. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48543-3 · Cited by 80
Wei, H., Suo, C., Gu, X., Shen, S., Lin, K., Zhu, C., Yan, K., Bian, Z., Chen, L., Zhang, T., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.011 · Cited by 86
M2 Kupffer Cells Promote Hepatocyte Senescence
Wan, J., Benkdane, M., Alons, E., Lotersztajn, S., & Pavoine, C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.014 · Cited by 77
Gut Microbiota and Hepatocellular Carcinoma
Tao, X., Wang, N., & Qin, W. (2015) · Gastrointestinal Tumors · doi:10.1159/000380895 · Cited by 79
The Hepatitis B Virus Receptor
Li, W. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125241 · Cited by 83
Ye, J., Li, T.-S., Xu, G., Zhao, Y.-M., Zhang, N.-P., Fan, J., & Wu, J. H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0229 · Cited by 77
Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers
Gingold, J. A., Zhu, D., Lee, D., Kaseb, A. O., & Chen, J. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.006 · Cited by 75
Emerging role and recent applications of metabolomics biomarkers in obesity disease research
Zhang, A., Sun, H. J., & Wang, X. (2017) · RSC Advances · doi:10.1039/c6ra28715h · Cited by 77
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 71
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Chen, Y., Liu, B., Wei, Y., & Kuang, D.-M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105966 · Cited by 73
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Nakatsuka, T., & Tateishi, R. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0095 · Cited by 79
Mitochondrial fatty acid oxidation drives senescence
Yamauchi, S., Sugiura, Y., Yamaguchi, J., Zhou, X., Takenaka, S., Odawara, T., Fukaya, S., Fujisawa, T., Naguro, I., Uchiyama, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado5887 · Cited by 82
Unno, T., SAKUMA, M., & Mitsuhashi, S. (2014) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.60.213 · Cited by 74
Enteral Nutrition in the Management of Pediatric and Adult Crohn’s Disease
Hansen, T. M., & Duerksen, D. R. (2018) · Nutrients · doi:10.3390/nu10050537 · Cited by 78
Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans
Farhana, L., Antaki, F., Murshed, F., Mahmud, H., Judd, S. L., Nangia‐Makker, P., Levi, E., Yu, Y., & Majumdar, A. P. N. (2018) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v9.i2.47 · Cited by 78
Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
Wu, J., Wang, S., Zheng, B. J., Qiu, X., Wang, H., & Chen, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669150 · Cited by 83
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.